UK markets closed

Hofseth BioCare ASA (0Q6H.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
3.0100-0.2900 (-8.79%)
At close: 09:56AM GMT

Hofseth BioCare ASA

Kipervikgata 13
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.no

Sector(s)
Industry
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Jon Olav OdegardChief Executive Officer1.7MN/AN/A
Dr. Bomi FramrozeChief Scientific Officer21.73MN/A1961
Mr. James BergerChief Commercial Officer7.81MN/AN/A
Ms. Angelika FlorvaagChief Quality Officer822kN/AN/A
Ms. Christel Elise KanliCFO & COON/AN/AN/A
Dr. Crawford CurrieHead of Medical R&D and DirectorN/AN/AN/A
Dr. Tanja SchafferEVP of Global Ingredients Division & CEO of HBC Switzerland GmbHN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.

Description

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.

Corporate governance

Hofseth BioCare ASA’s ISS governance QualityScore as of 1 February 2024 is 7. The pillar scores are Audit: 10; Board: 4; Shareholder rights: 1; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.